On 20 May 2019, the German government held for the second time in the current legislative period top-level discussions as part of its Pharma Dialogue. The meeting took place under the heading of “Quality of care and supply security”.
BIO Deutschland has issued a statement commenting on a draft bill concerning tax incentives for research and development (RefE FZuIG), which the Federal Ministry of Finance submitted in mid-April and which has since been approved by the Federal Cabinet.
The Swiss Biotech Day was held in Basel in early May, drawing more than 850 attendees from 25 countries. On invitation from Switzerland Global Enterprise, the official export promotion agency of the Swiss government, BIO Deutschland gave the introductory talk for the panel titled, “R&D Cooperation Forum with a Focus on Germany and Italy”.
Attend and present – European Business Development Conference for pharma and biotech to be held in Heidelberg
The European Business Development Conference (EBDC) is BIO Deutschland’s special networking event for decision makers from the pharma and biotech industries and from the investment sector. EBDC 2019 will take place at the German Cancer Research Center (DKFZ) in Heidelberg on 25 and 26 September.